Jadranka Morović‐Vergles

2.3k total citations
54 papers, 344 citations indexed

About

Jadranka Morović‐Vergles is a scholar working on Rheumatology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jadranka Morović‐Vergles has authored 54 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Rheumatology, 8 papers in Pathology and Forensic Medicine and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jadranka Morović‐Vergles's work include Rheumatoid Arthritis Research and Therapies (18 papers), Systemic Lupus Erythematosus Research (8 papers) and Spondyloarthritis Studies and Treatments (7 papers). Jadranka Morović‐Vergles is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (18 papers), Systemic Lupus Erythematosus Research (8 papers) and Spondyloarthritis Studies and Treatments (7 papers). Jadranka Morović‐Vergles collaborates with scholars based in Croatia, Japan and United Kingdom. Jadranka Morović‐Vergles's co-authors include Kres̆imir Gales̃ić, Boris Brkljačić, Stjepan Gamulin, Vinko Vidjak, Velimir Božikov, Andrija Hebrang, Branimir Anić, Simeon Grazio, Filip Čulo and Srđan Novak and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Molecules.

In The Last Decade

Jadranka Morović‐Vergles

50 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jadranka Morović‐Vergles Croatia 10 133 78 58 46 39 54 344
K.P. Tiev France 10 82 0.6× 70 0.9× 58 1.0× 18 0.4× 51 1.3× 23 429
А. П. Ребров Russia 9 178 1.3× 41 0.5× 29 0.5× 29 0.6× 42 1.1× 121 418
Ferhan Karademır Türkiye 14 36 0.3× 49 0.6× 56 1.0× 21 0.5× 50 1.3× 37 410
A. Kettaneh France 4 82 0.6× 31 0.4× 52 0.9× 91 2.0× 40 1.0× 9 336
Sylvia Bort-Martí Spain 8 63 0.5× 61 0.8× 199 3.4× 22 0.5× 49 1.3× 9 420
Idrissia Abdelmouttaleb France 11 201 1.5× 36 0.5× 42 0.7× 62 1.3× 134 3.4× 13 429
Erkan Şengül Türkiye 12 41 0.3× 44 0.6× 65 1.1× 9 0.2× 50 1.3× 30 354
Aytekin Güven Türkiye 13 62 0.5× 50 0.6× 56 1.0× 10 0.2× 90 2.3× 42 398
Gustavo Adolpho Moreira Faulhaber Brazil 11 111 0.8× 49 0.6× 74 1.3× 39 0.8× 43 1.1× 32 388
Taner Koçak Türkiye 15 91 0.7× 137 1.8× 43 0.7× 14 0.3× 128 3.3× 30 488

Countries citing papers authored by Jadranka Morović‐Vergles

Since Specialization
Citations

This map shows the geographic impact of Jadranka Morović‐Vergles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jadranka Morović‐Vergles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jadranka Morović‐Vergles more than expected).

Fields of papers citing papers by Jadranka Morović‐Vergles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jadranka Morović‐Vergles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jadranka Morović‐Vergles. The network helps show where Jadranka Morović‐Vergles may publish in the future.

Co-authorship network of co-authors of Jadranka Morović‐Vergles

This figure shows the co-authorship network connecting the top 25 collaborators of Jadranka Morović‐Vergles. A scholar is included among the top collaborators of Jadranka Morović‐Vergles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jadranka Morović‐Vergles. Jadranka Morović‐Vergles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miler, Marijana, Nora Nikolac, Ivana Ćelap, et al.. (2021). Association of polymorphisms in promoter region of TNF-α -238 and -308 with clinical outcomes in patients with immune-mediated inflammatory diseases on anti-TNF therapy. Rheumatology International. 41(12). 2195–2203. 6 indexed citations
2.
Morović‐Vergles, Jadranka, Tonko Vlak, Srđan Novak, et al.. (2015). Differences in the prevalence and characteristics of metabolic syndrome in rheumatoid arthritis and osteoarthritis: a multicentric study. Rheumatology International. 35(12). 2047–2057. 18 indexed citations
3.
Morović‐Vergles, Jadranka, et al.. (2015). Ambulatory arterial stiffness index and carotid intima‐media thickness in hypertensive rheumatoid patients: a comparative cross‐sectional study. International Journal of Rheumatic Diseases. 20(12). 1998–2002. 4 indexed citations
4.
Morović‐Vergles, Jadranka. (2014). Svjetski dan artritisa i desetogodišnjica djelovanja Hrvatskog nacionalnog odbora Desetljeća kostiju i zglobova. 20. 1 indexed citations
5.
Gračanin, Ana Gudelj, et al.. (2014). AB1030 Efficiency of Spoken Medical Advice in Quitting Smoking in Patients Smokers with Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 73. 1141–1141. 1 indexed citations
6.
Žic, Rado, et al.. (2014). Focal Myositis of Lower Extremity Responsive to Botulinum A Toxin. Clinical Neuropharmacology. 37(2). 55–57. 2 indexed citations
7.
Horvatić, Ivica, et al.. (2014). [Henoch-Schönlein purpura with late-onset necrotising glomerulonephritis--a case report].. PubMed. 61(1). 40–5. 2 indexed citations
8.
Grazio, Simeon, Branimir Anić, Nada Čikeš, et al.. (2013). Prijedlog Hrvatskog reumatološkog društva HLZ-a za primjenu inhibitora TNF-α u odraslih bolesnika sa spondiloartritisima, 2013.. Hrčak Portal of scientific journals of Croatia (University Computing Centre). 60(1). 52–56.
9.
Pergolizzi, Joseph V., Cayetano Alegre, David R. Blake, et al.. (2011). Current Considerations for the Treatment of Severe Chronic Pain: The Potential for Tapentadol. Pain Practice. 12(4). 290–306. 34 indexed citations
10.
Morović‐Vergles, Jadranka, et al.. (2011). [Extra-articular manifestations of seronegative spondyloarthritides].. PubMed. 58(2). 54–6. 1 indexed citations
11.
Morović‐Vergles, Jadranka, et al.. (2010). [Proposal for biologic drugs therapy in rheumatoid arthritis].. PubMed. 57(1). 29–35. 2 indexed citations
12.
Romić, Željko, et al.. (2010). Anti-cyclic citrullinated peptide and rheumatoid factor in HIV positive patients. Rheumatology International. 31(12). 1607–1610. 8 indexed citations
13.
Morović‐Vergles, Jadranka, et al.. (2010). The importance of urgent cytological examination of synovial fluids in differentiation inflammatory and non-inflammatory joint diseases.. PubMed. 34(1). 145–52. 7 indexed citations
14.
Jajić, Zrinka, et al.. (2008). Preporuke Hrvatskog reumatološkog društva za anti-TNF terapiju u odraslih bolesnika koji boluju od spondiloartritisa. 54(1). 20–30. 1 indexed citations
15.
Morović‐Vergles, Jadranka, et al.. (2008). Cyclic adenosine 5′-monophosphate in synovial fluid of rheumatoid arthritis and osteoarthritis patients. Rheumatology International. 29(2). 167–171. 16 indexed citations
16.
Morović‐Vergles, Jadranka, et al.. (2007). Primary Sjögren’s syndrome presenting as hypokalemic paralysis. Annals of Saudi Medicine. 27(2). 125–127. 4 indexed citations
17.
Gales̃ić, Kres̆imir, et al.. (2004). [Primary Sjögren's syndrome and hypokalaemic paralysis--case report].. PubMed. 51(1). 19–22. 1 indexed citations
18.
Morović‐Vergles, Jadranka. (2003). [Pathophysiology of rheumatoid arthritis].. PubMed. 50(2). 15–7. 2 indexed citations
19.
Gales̃ić, Kres̆imir, et al.. (2001). Hypokalemic metabolic alkalosis--three case reports.. PubMed. 55(4-5). 219–23.
20.
Brkljačić, Boris, et al.. (1994). Intrarenal duplex Doppler sonographic evaluation of unilateral native kidney obstruction.. Journal of Ultrasound in Medicine. 13(3). 197–204. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K.P. Tiev Breakdown of academic impact, for papers by А. П. Ребров Breakdown of academic impact, for papers by Ferhan Karademır Breakdown of academic impact, for papers by A. Kettaneh Breakdown of academic impact, for papers by Sylvia Bort-Martí Breakdown of academic impact, for papers by Idrissia Abdelmouttaleb Breakdown of academic impact, for papers by Erkan Şengül Breakdown of academic impact, for papers by Aytekin Güven Breakdown of academic impact, for papers by Gustavo Adolpho Moreira Faulhaber Breakdown of academic impact, for papers by Taner Koçak
Rankless by CCL
2026